Upper Respiratory Infections and Respiratory Adverse Events and Interventions in Emergency Department Sedation of Children.
Daniel S Tsze, Nick Barrowman, Maala Bhatt
Annals of emergency medicine April 22, 2025 DOI: 10.1016/j.annemergmed.2025.03.016 via PubMed
Summary
AI-generated from the abstractChildren with upper respiratory infections (URIs) undergoing sedation in emergency departments (EDs) do not face a higher risk of respiratory complications or need for serious interventions compared to those without URIs. A secondary analysis of 6,292 children aged 17 years or younger who received parenteral sedation in six pediatric EDs found that the adjusted odds of any respiratory adverse event, serious adverse event, or serious intervention (such as bag-valve-mask ventilation or intubation) were not significantly elevated. The odds ratios were 1.00, 0.53, and 1.08, respectively, with confidence intervals crossing 1.0, indicating no detectable increase in risk.
Study at a glance
| Characteristics | Prospective cohort study (secondary analysis) Peer reviewed |
|---|---|
| Sample size | 6,292 |
| Population | Children aged 17 years or younger who received parenteral sedation for a painful procedure in 1 of 6 pediatric emergency departments |
| Intervention | parenteral sedation |
| Topics | Ketamine |
| Keywords | Adverse events Upper respiratory infection Pediatric sedation Respiratory infections |
| Citations | 1 |
| Key finding | No increase in risk of respiratory adverse events or serious respiratory interventions was associated with upper respiratory infection in children undergoing emergency department sedation. |
Abstract
Children with upper respiratory infections (URIs) have an increased risk of respiratory adverse events when undergoing operative anesthesia and in general populations of children receiving procedural sedation. It is unclear if children with URI undergoing emergency department (ED) sedation share the same increased risk. We aimed to determine if the presence of a URI in children undergoing ED sedation is associated with increased risk of respiratory adverse events and serious respiratory interventions. We conducted a secondary analysis of a prospective cohort study of children aged 17 years or younger who received parenteral sedation for a painful procedure in 1 of 6 pediatric EDs. A multivariable regression model was used to identify potential associations between URI and respiratory adverse events, serious respiratory adverse events (ie, complete airway obstruction, apnea, laryngospasm, clinically apparent pulmonary aspiration, and death), and serious respiratory interventions (ie, bag-valve-mask ventilation and endotracheal intubation). We analyzed 6,292 children; 444 (7.1%) had a URI. The risk of respiratory adverse events, serious respiratory adverse events, or serious respiratory interventions was adjusted odds ratio (aOR) 1.00 (95% confidence interval [CI] 0.78 to 1.29), 0.53 (95% CI 0.18 to 1.58), and 1.08 (95% CI 0.68 to 1.71), respectively. In this study, we found no increase in risk of any respiratory adverse events or serious respiratory interventions associated with URI in children undergoing ED sedation.